Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.

Zhou, Ru; Yazdanifar, Mahboubeh; Roy, Lopamudra Das; Whilding, Lynsey M; Gavrill, Artemis; Maher, John; Mukherjee, Pinku

Zhou, Ru; Yazdanifar, Mahboubeh; Roy, Lopamudra Das; Whilding, Lynsey M; Gavrill, Artemis; Maher, John; Mukherjee, Pinku.

Afiliación

Zhou R; Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, United States.
Yazdanifar M; Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, United States.
Roy LD; Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, United States.
Whilding LM; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital Campus, London, United Kingdom.
Gavrill A; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital Campus, London, United Kingdom.
Maher J; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital Campus, London, United Kingdom.
Mukherjee P; Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, United States.

Front Immunol ; 11: 628776, 2020.

Article en En | MEDLINE | ID: mdl-33365036

RESUMEN

[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

Palabras clave

MUC1; MUC28z CAR T cells; TAB004; immunotherapy; triple-negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google